Literature DB >> 11888564

Role of serotonin(2C) receptors in the control of brain dopaminergic function.

Vincenzo Di Matteo1, Marisa Cacchio, Camillo Di Giulio, Ennio Esposito.   

Abstract

There is substantial evidence that the functional status of mesocorticolimbic dopaminergic (DA) system originating in the ventral tegmental area (VTA) is under a phasic and tonic inhibitory control by the serotonergic system, which acts by stimulating serotonin(2C) (5-HT(2C)) receptor subtypes. This assertion is based upon a number of electrophysiological and biochemical data showing that 5-HT(2C) receptor agonists decrease, while 5-HT(2C) receptor antagonists enhance mesocorticolimbic DA function. On the other hand, it does not seem that 5-HT(2C) receptors play a relevant role in the control of nigrostriatal DA system originating in the substantia nigra pars compacta (SNc). The authors of this article review the most relevant data regarding the role of 5-HT(2C) receptors in the control of brain DA function and underline the importance of this subject in the search of new therapies for neuropsychiatric disorders such as depression, schizophrenia, drug addiction, and Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888564     DOI: 10.1016/s0091-3057(01)00705-5

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  42 in total

1.  A systematic investigation of the differential roles for ventral tegmentum serotonin 1- and 2-type receptors on food intake in the rat.

Authors:  Wayne E Pratt; Kara A Clissold; Peagan Lin; Amanda E Cain; Alexa F Ciesinski; Thomas R Hopkins; Adeolu O Ilesanmi; Erin A Kelly; Zachary Pierce-Messick; Daniel S Powell; Ian A Rosner
Journal:  Brain Res       Date:  2016-07-16       Impact factor: 3.252

2.  Serotonin selectively modulates reward value in human decision-making.

Authors:  Ben Seymour; Nathaniel D Daw; Jonathan P Roiser; Peter Dayan; Ray Dolan
Journal:  J Neurosci       Date:  2012-04-25       Impact factor: 6.167

3.  Loss of thalamic serotonin transporters in early drug-naïve Parkinson's disease patients is associated with tremor: an [(123)I]beta-CIT SPECT study.

Authors:  V Caretti; D Stoffers; A Winogrodzka; I-U Isaias; G Costantino; G Pezzoli; C Ferrarese; A Antonini; E-Ch Wolters; J Booij
Journal:  J Neural Transm (Vienna)       Date:  2008-03-12       Impact factor: 3.575

Review 4.  Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.

Authors:  P De Deurwaerdère; M Lagière; M Bosc; S Navailles
Journal:  Exp Brain Res       Date:  2013-04-25       Impact factor: 1.972

5.  Lorcaserin and CP-809101 reduce motor impulsivity and reinstatement of food seeking behavior in male rats: Implications for understanding the anti-obesity property of 5-HT2C receptor agonists.

Authors:  Guy A Higgins; Leo B Silenieks; Everett B Altherr; Cam MacMillan; Paul J Fletcher; Wayne E Pratt
Journal:  Psychopharmacology (Berl)       Date:  2016-05-30       Impact factor: 4.530

Review 6.  Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data.

Authors:  B Scholtissen; F R J Verhey; H W M Steinbusch; A F G Leentjens
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

7.  Effects of 5-hydroxytryptamine 2C receptor agonist MK212 and 2A receptor antagonist MDL100907 on maternal behavior in postpartum female rats.

Authors:  Weihai Chen; Qi Zhang; Wenxin Su; Haorong Zhang; Yu Yang; Jing Qiao; Nan Sui; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2013-12-07       Impact factor: 3.533

8.  Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

Authors:  Edward D Levin; Susan Slade; Michael Johnson; Ann Petro; Kofi Horton; Paul Williams; Amir H Rezvani; Jed E Rose
Journal:  Eur J Pharmacol       Date:  2008-10-17       Impact factor: 4.432

9.  Behavioral, pharmacological and neuroanatomical analysis of serotonin 2C receptor agonism on maternal behavior in rats.

Authors:  Ruiyong Wu; Jun Gao; Shinnyi Chou; Collin Davis; Ming Li
Journal:  Psychoneuroendocrinology       Date:  2016-08-16       Impact factor: 4.905

10.  Drug-drug conditioning between citalopram and haloperidol or olanzapine in a conditioned avoidance response model: implications for polypharmacy in schizophrenia.

Authors:  Nathan L Sparkman; Ming Li
Journal:  Behav Pharmacol       Date:  2012-10       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.